Accuray Sets Nov. 13 Virtual Shareholder Meeting for Key Votes

Ticker: ARAY · Form: DEF 14A · Filed: Oct 1, 2025 · CIK: 1138723

Sentiment: mixed

Topics: Proxy Statement, Shareholder Meeting, Corporate Governance, Executive Compensation, Equity Incentive Plan, Auditor Ratification, Director Election

Related Tickers: ARAY

TL;DR

**ARAY's upcoming shareholder meeting is a must-watch for investors, with the 2026 Equity Incentive Plan posing a potential dilution risk that could outweigh governance stability.**

AI Summary

Accuray Inc. (ARAY) is holding its 2025 Annual Meeting of Stockholders on November 13, 2025, to address several key proposals. Stockholders will vote on the election of three Class I directors to serve until the 2028 Annual Meeting, a critical governance decision. A significant proposal is the approval of the 2026 Equity Incentive Plan, which will impact future executive and employee compensation and potentially dilute existing shareholder value. Additionally, shareholders will cast an advisory vote on named executive officer compensation for fiscal year 2025, providing feedback on the company's pay practices. The ratification of Grant Thornton LLP as the independent registered public accounting firm for fiscal year 2026 is also on the agenda, ensuring financial oversight. The meeting will be held virtually, allowing for broader stockholder participation, with 112,719,901 shares of common stock outstanding as of the September 17, 2025 record date, each entitled to one vote. The company will bear the solicitation costs, including a $15,000 fee for MacKenzie Partners, Inc. to assist with proxy solicitation.

Why It Matters

This DEF 14A filing outlines critical governance and compensation decisions for Accuray Inc. (ARAY) investors. The approval of the 2026 Equity Incentive Plan could lead to significant stock-based compensation, potentially diluting existing shareholder value, which directly impacts investor returns. The advisory 'Say on Pay' vote for fiscal 2025 executive compensation provides a direct channel for investors to influence the company's approach to executive incentives, a key factor in attracting and retaining top talent in the competitive medical device industry. For employees, the new equity plan could offer enhanced incentives, while customers and the broader market will watch for stable leadership and sound financial practices, especially with the ratification of Grant Thornton LLP as auditors, signaling continued financial transparency.

Risk Assessment

Risk Level: medium — The approval of the 2026 Equity Incentive Plan introduces a medium risk due to potential shareholder dilution, as new equity awards could increase the number of outstanding shares. While the filing doesn't specify the exact number of shares reserved for the plan, any new equity plan inherently carries this risk. The advisory 'Say on Pay' vote for fiscal 2025 executive compensation, if met with significant dissent, could signal investor dissatisfaction with compensation practices, potentially impacting executive retention and company performance.

Analyst Insight

Investors should carefully review the details of the proposed 2026 Equity Incentive Plan to understand its potential dilutive impact and vote accordingly. They should also scrutinize the fiscal 2025 executive compensation details and cast an informed advisory vote, signaling their stance on executive pay practices to the Board.

Key Numbers

Key Players & Entities

FAQ

What are the key proposals for Accuray's 2025 Annual Meeting of Stockholders?

Accuray's 2025 Annual Meeting, scheduled for November 13, 2025, includes proposals to elect three Class I directors, approve the 2026 Equity Incentive Plan, conduct an advisory vote on named executive officer compensation for fiscal year 2025, and ratify Grant Thornton LLP as the independent registered public accounting firm for fiscal year 2026.

When is Accuray's 2025 Annual Meeting and how can stockholders attend?

Accuray's 2025 Annual Meeting will be held virtually via live audio webcast on Thursday, November 13, 2025, at 9:00 a.m. PST. Stockholders can attend and participate by visiting www.virtualshareholdermeeting.com/ARAY2025 and entering their control number.

What is the record date for voting at Accuray's 2025 Annual Meeting?

The record date for Accuray's 2025 Annual Meeting is September 17, 2025. Only holders of record and beneficial owners of shares of common stock at the close of business on this date are entitled to notice of, to attend, and to vote at the Annual Meeting.

How many shares of Accuray common stock are outstanding and entitled to vote?

As of the record date, September 17, 2025, there were 112,719,901 shares of Accuray common stock issued and outstanding. Each share is entitled to one vote on each item brought before the stockholders at the Annual Meeting.

What is the significance of the 2026 Equity Incentive Plan for Accuray shareholders?

The approval of Accuray's 2026 Equity Incentive Plan is significant because it will govern future equity awards to executives and employees. While intended to incentivize performance, such plans can lead to dilution of existing shareholder value if a substantial number of new shares are issued.

Who is Accuray's independent registered public accounting firm for fiscal year 2026?

Grant Thornton LLP has been appointed as Accuray's independent registered public accounting firm for the fiscal year ending June 30, 2026. Stockholders will vote on the ratification of this appointment at the Annual Meeting.

What is a 'broker non-vote' and how does it affect voting at Accuray's meeting?

A 'broker non-vote' occurs when a broker holding shares in street name does not receive timely instructions from the beneficial owner and cannot vote on non-routine matters. For Accuray's meeting, only the ratification of Grant Thornton LLP is routine; thus, broker non-votes will not affect the outcome of non-routine matters like director elections or the equity plan.

Who is soliciting proxies for Accuray and what are the costs involved?

Proxies are being solicited on behalf of Accuray's Board of Directors. The company will bear the entire cost of solicitation, including a fee of approximately $15,000 paid to MacKenzie Partners, Inc. for their assistance.

Can Accuray stockholders submit questions in advance of the virtual Annual Meeting?

Yes, Accuray stockholders can submit questions in advance of the Annual Meeting by emailing their question, along with proof of ownership, to investor.relations@accuray.com. They can also submit questions live during the virtual meeting.

What are the stock ownership requirements for Accuray's non-employee directors?

The DEF 14A filing indicates that Accuray has stock ownership requirements for its non-employee directors, as detailed in the 'Director Compensation Program' section, specifically under 'Stock Ownership Requirements' on page 65.

Industry Context

Accuray Inc. operates in the medical device industry, specifically focusing on radiation oncology solutions for cancer treatment. The sector is characterized by significant R&D investment, regulatory hurdles, and a competitive landscape with both established players and emerging technologies. Trends include the increasing demand for precision medicine, minimally invasive techniques, and integrated software solutions for treatment planning and delivery.

Regulatory Implications

As a medical device company, Accuray is subject to stringent regulatory oversight from bodies like the FDA in the U.S. and similar agencies globally. Changes in healthcare policy, reimbursement rates, and evolving regulatory requirements for device approval and post-market surveillance can significantly impact the company's operations and market access.

What Investors Should Do

  1. Review the proposed 2026 Equity Incentive Plan carefully, considering its potential dilutive effects and alignment with long-term shareholder value creation.
  2. Evaluate the company's executive compensation practices for fiscal year 2025 and cast an informed advisory vote ('Say on Pay').
  3. Confirm the ratification of Grant Thornton LLP as the independent auditor to ensure continued financial transparency and oversight.
  4. Vote for the election of the proposed Class I directors, assessing their qualifications and contributions to corporate governance.

Key Dates

Glossary

DEF 14A
A proxy statement filed with the SEC by publicly traded companies to solicit shareholder votes for an annual meeting. (This document contains all the information shareholders need to make informed voting decisions on proposals presented at the annual meeting.)
Class I directors
Directors who are part of a staggered board structure, typically serving three-year terms. (Shareholders will vote on the election of three Class I directors, impacting the composition and governance of the Board of Directors.)
Equity Incentive Plan
A plan that allows a company to grant stock options, restricted stock units, or other equity-based awards to employees and executives. (The approval of the 2026 Equity Incentive Plan is a key proposal that will affect future compensation and potential shareholder dilution.)
Named Executive Officer (NEO)
The top executive officers of a company, typically the CEO, CFO, and other highest-paid executives. (Shareholders will cast an advisory vote on the compensation of Accuray's NEOs for fiscal year 2025.)
Independent Registered Public Accounting Firm
An external audit firm that is independent of the company it audits, responsible for expressing an opinion on the fairness of financial statements. (The ratification of Grant Thornton LLP ensures continued independent oversight of Accuray's financial reporting.)
Proxy Solicitation
The process by which a company requests shareholders to grant authority (a proxy) to vote their shares in a specified manner. (Accuray is using a proxy solicitor, MacKenzie Partners, Inc., to assist in gathering shareholder votes for the annual meeting.)

Year-Over-Year Comparison

This filing pertains to the 2025 Annual Meeting, with the fiscal year ending June 30, 2025. Specific comparative financial metrics (revenue, net income, margins) from the prior year's DEF 14A are not directly available within this document's provided text. However, the focus on a new equity incentive plan and advisory vote on executive compensation suggests a continued emphasis on aligning management incentives with company performance and shareholder interests, a common theme in proxy statements.

Filing Stats: 4,848 words · 19 min read · ~16 pages · Grade level 12.6 · Accepted 2025-10-01 16:02:17

Key Financial Figures

Filing Documents

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 53 Fiscal 2025 Summary Compensation Table 53 Outstanding Equity Awards at Fiscal 2025 Year End Table 54 Potential Payments and Benefits Upon Termination or Change in Control 56 Pay Versus Performance 60 COMPENSATION OF NON-EMPLOYEE DIRECTORS 63 Director Compensation Table for Fiscal 2025 63 Director Compensation Program 64 Cash Compensation 64 Equity Compensation 64 Stock Ownership Requirements 65 EQUITY COMPENSATION PLAN INFORMATION 66 Policies and Practices for Granting Certain Equity Awards 66

SECURITY OWNERSHIP

SECURITY OWNERSHIP 67

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 67 Delinquent Section 16(a) Reports 69 CORPORATE GOVERNANCE AND BOARD OF DIRECTORS MATTERS 70 EXECUTIVE OFFICERS 77 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 78 WHERE YOU CAN FIND ADDITIONAL INFORMATION 79 OTHER MATTERS 81 Appendix A – 2026 Equity Incentive Plan A-1 iii TABLE OF CONTENTS PROXY STATEMENT FOR ACCURAY INCORPORATED 2025 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON NOVEMBER 13, 2025 This proxy statement ("Proxy Statement") is furnished to our stockholders of record as of the close of business on September 17, 2025 (the "Record Date"), in connection with the solicitation of proxies by our Board of Directors (the "Board") for use in connection with our 2025 Annual Meeting of Stockholders, and any adjournment, postponement or other delay thereof (the "Annual Meeting"), to be held virtually via live audio webcast on Thursday, November 13, 2025, at 9:00 a.m. PST. In order to attend and vote at the Annual Meeting, please follow the instructions in the section titled " Questions and Answers Regarding This Solicitation and Voting at the Annual Meeting—How can I attend the Annual Meeting virtually ?" This Proxy Statement and the proxy card are first being made available to our stockholders on or about October 1, 2025. Our Company's fiscal year ended on June 30, 2025. QUESTIONS AND ANSWERS REGARDING THIS SOLICITATION AND VOTING AT THE ANNUAL MEETING Why did I receive a Notice of Internet Availability of Proxy Materials? We are pleased to again be using the U.S. Securities and Exchange Commission (the "SEC") rule that allows companies to furnish proxy materials to their stockholders primarily over the Internet instead of mailing printed copies of those materials to each stockholder. On October 1, 2025, we mailed to our stockholders (other than those who previously requested electronic or paper delivery) a Notice of Internet Availability of Proxy Mate

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing